Effects of a NR2B Selective NMDA Glutamate Antagonist, CP-101,606, on Dyskinesia and Parkinsonism

Glutamate antagonists decrease dyskinesia and augment the antiparkinsonian effects of levodopa in animal models of Parkinson’s disease (PD). In a randomized, double-blind, placebo-controlled clinical trial we investigated the acute effects of placebo and two doses of a NR2B subunit selective NMDA gl...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Nutt, John G., Gunzler, Steven A, Kirchhoff, Trish, Hogarth, Penelope, Weaver, Jerry L., Krams, Michael, Jamerson, Brenda, Menniti, Frank S., Landen, Jaren W.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2008
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3390310/
https://ncbi.nlm.nih.gov/pubmed/18759356
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mds.22169
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller